NEW YORK (GenomeWeb News) – Invitrogen last week filed a patent infringement suit against GE Healthcare and other unnamed defendants for allegedly infringing six patents, four of which expired earlier this year.
 
Invitrogen said in its complaint filed in the US District Court for the Eastern District of Texas Tyler Division that GE Healthcare’s CyScript reverse transcriptase enzymes and kits infringe all six of the patents.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Genetic genealogy has led to an arrest in another cold case, dating back to 1987.

Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.

In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.

Wired reports that 23andMe is trying to bolster its outside collaborations.